Cited by

• Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

  Sebban C, Dussart S, Fuhrmann C, Ghesquieres H, Rodrigues I, Geoffrois L, Devaux Y, Lancry L, Chvetzoff G, Bachelot T, Chelghoum M, Biron P. Sebban C, et al. Support Care Cancer. 2008 Sep;16(9):1017-23. doi: 10.1007/s00520-007-0383-z. Epub 2008 Jan 15. Support Care Cancer. 2008. PMID: 18197434 Clinical Trial.
• Prevalence, microbiology, and antimicrobial susceptibility profile of bacterial skin and soft tissue infections in pediatric patients with malignancies at a referral teaching hospital in Shiraz, Iran.

  Abdipour Mehrian SR, Noushadi F, Pourasghar Y, Farkarian A, Meftah E, Homayounifar F, Amanati A. Abdipour Mehrian SR, et al. BMC Infect Dis. 2025 May 16;25(1):707. doi: 10.1186/s12879-025-11059-2. BMC Infect Dis. 2025. PMID: 40380338 Free PMC article.
• Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia.

  Sakaguchi S, Saito M, Tsuji H, Asahara T, Takata O, Fujimura J, Nagata S, Nomoto K, Shimizu T. Sakaguchi S, et al. J Clin Microbiol. 2010 May;48(5):1624-8. doi: 10.1128/JCM.01724-09. Epub 2010 Mar 29. J Clin Microbiol. 2010. PMID: 20351213 Free PMC article.
• Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia.

  Kim TH, Choi YW, Ahn MS, Choi YS, Lee HW, Jeong SH, Kang SY, Choi JH, Park JS, Lee HY. Kim TH, et al. Ann Hematol. 2021 Nov;100(11):2825-2830. doi: 10.1007/s00277-021-04673-y. Epub 2021 Sep 30. Ann Hematol. 2021. PMID: 34591161
• Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

  Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH. Lee DG, et al. Korean J Intern Med. 2011 Jun;26(2):220-52. doi: 10.3904/kjim.2011.26.2.220. Epub 2011 Jun 1. Korean J Intern Med. 2011. PMID: 21716917 Free PMC article. Review.